export interface FAQItem {
  question: string;
  answer: string;
}

export const faqData: FAQItem[] = [
  {
    question: "What is AmacaThera's mission?",
    answer: "To revolutionize drug delivery with our injectable hydrogel technology — extending the life and performance of therapeutics across multiple indications."
  },
  {
    question: "What makes AmacaGel™ unique?",
    answer: "A thermoresponsive, biocompatible hydrogel that transitions from liquid to gel at body temperature, allowing precise, sustained drug release for days to weeks."
  },
  {
    question: "What stage is your lead program (AMT-143)?",
    answer: "Completed Phase 1 safety studies; preparing for Phase 2 clinical trials in postoperative pain management."
  },
  {
    question: "Is the platform applicable beyond pain management?",
    answer: "Yes — AmacaGel™ is modular and compatible with diverse payloads, including biologics, peptides, and small molecules, with applications in oncology, infectious disease, and animal health."
  },
  {
    question: "What differentiates AmacaThera as a platform company?",
    answer: "We're not limited to one drug. Our IP-protected hydrogel system can be tailored for multiple therapeutic classes, positioning us as a drug-delivery enabler across the industry."
  },
  {
    question: "What is your partnership strategy?",
    answer: "We collaborate with pharma and biotech partners through licensing and co-development, enabling them to integrate our delivery system into their therapeutic programs."
  }
];